Researchers recently found a 2-way association between onset of fibromyalgia (FM) and that of migraine in patients with migraine and those with FM, respectively.
Using nationwide data, researchers recently found a 2-way association between onset of fibromyalgia (FM) and that of migraine in patients with migraine and those with FM, respectively.
Migraine and FM are common chronic pain disorders that tend to coexist, and a major symptom of FM is headache. Previous studies have reported that about 20% to 36% of patients with migraine also have FM. Similarly, the frequency of migraine in patients with FM ranges from 45% to 80%, suggesting that migraine is common in patients with FM. However, no explanations have been provided for the rate of co-occurrence.
This study examined whether these 2 conditions show any mutual influences and considered the conditions in the same context. This retrospective, longitudinal cohort study was conducted using data obtained from a nationwide healthcare database. This study, consisting of patients who were diagnosed between 2000 and 2010, had 2 arms:
Control subjects who had neither FM nor migraine were recruited and matched with the FM and migraine patients by sex, age, and index date of diagnosis. Each control cohort was 4 times the size of the corresponding study cohort. Follow-up for the control and study cohorts was conducted until the end of 2011.
The incidence rates of FM and migraine were calculated in arms 1 and 2, respectively. The overall incidence of migraine was greater in the FM cohort than in the corresponding control cohort (4.39 vs 2.07 per 1000 person-years [PY]; crude hazard ratio [HR], 2.12; 95% CI, 1.96-2.30; adjusted hazard ratio (aHR), 1.89; 95% CI, 1.75-2.05).
After adjustment for sex, age, and comorbidities, the overall incidence of FM in the migraine cohort was 1.57 times greater than that in the corresponding control cohort (7.01 vs 4.49 per 1000 PY; aHR, 1.52; 95% CI, 1.39-1.65).
The authors said this study was the first to reveal a population-based bidirectional association between onset of FM and that of migraine in patients with migraine and those with FM, respectively. The risk of migraine was reportedly greater than that of FM. The incidence rates of FM in the migraine cohort and migraine in the FM cohort increased with age in both directions. However, the HRs relative to the corresponding comparison groups were weakened with increases in age.
Reference
Penn I-W, Chuang E, Chuang T-Y, Lin CL, Kao CH. Bidirectional association between migraine and fibromyalgia: retrospective cohort analyses of two populations [published online April 8, 2019]. BMJ Open. doi: 10.1136/bmjopen-2018-026581.
Prior Authorization Requirements for Calcitonin Gene-Related Peptide Antagonists
April 20th 2023This quantitative and qualitative analysis highlights differences in prior authorization requirements for migraine drugs from nearly 50 managed care organizations and summarizes broad types of criteria used.
Read More
Update on Migraine Patient Care Challenges During the Pandemic
October 5th 2021Migraines plague some 35 million Americans, the majority of them women in their 30s and 40s, and disabling pain and symptoms are linked to lost productivity at work, school, and home. On this episode of Managed Care Cast, we bring you an excerpt of an interview with a headache specialist about the extra challenges for patients and providers during the pandemic.
Listen
CGRP Inhibitors: A Promising New Class of Drugs for Migraine
November 14th 2018This fall, The American Journal of Managed Care® convened a panel of experts on migraine to discuss calcitonin gene-related peptide (CGRP) inhibitors, an emerging therapy for the condition, which affects 39 million people in the United States.
Listen